{"id":"W4385707163","doi":"10.1097/01.hs9.0000970568.75232.84","title":"P916: LONG-TERM OUTCOMES WITH ISATUXIMAB-CARFILZOMIB-DEXAMETHASONE (ISA-KD) IN RELAPSED MULTIPLE MYELOMA PATIENTS WITH 1Q21+ STATUS: UPDATED RESULTS FROM THE PHASE 3 IKEMA STUDY","year":2023,"lang":"en","type":"article","venue":"HemaSphere","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Internal medicine; Medicine; Carfilzomib; Multiple myeloma; Oncology; Subgroup analysis; Gastroenterology; Confidence interval; Bortezomib","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001805728,0.0005170531,0.001250842,0.0002212328,0.0002396873,0.0009257593,0.0004702756,0.0007540391,0.001113028],"category_scores_gemma":[0.001244646,0.0001609089,0.002161529,0.0004865022,0.0002683265,0.0005980631,0.0004424053,0.001568798,0.0003075859],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005428399,"about_ca_system_score_gemma":0.0006174811,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000759491,"about_ca_topic_score_gemma":0.001663761,"domain_scores_codex":[0.9995378,0.0001923428,0.00004232212,0.0000781714,0.00007475154,0.00007469617],"domain_scores_gemma":[0.9989321,0.0002215684,0.0004705417,0.00007497725,0.00008641656,0.0002143962],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5266106,0.005677601,0.1674847,0.002641515,0.01324834,0.0003760245,0.0003132053,0.004896929,0.01014088,0.000228457,0.008866233,0.2595155],"study_design_scores_gemma":[0.09828088,0.1671949,0.6988998,0.0004463304,0.01665538,0.001196336,0.0001860263,0.002595205,0.003163096,0.0004976707,0.01079011,0.00009431597],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9803155,0.01535559,0.0002685128,0.0005430554,0.0001009909,0.0001623207,0.002357377,0.00003412976,0.0008625278],"genre_scores_gemma":[0.9903729,0.00381082,0.0002573687,0.0005714817,0.0001721321,0.0001658236,0.004054221,0.00001130363,0.0005839244],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001805728,"threshold_uncertainty_score":0.009549677,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04083135418477333,"score_gpt":0.3257352402816293,"score_spread":0.2849038860968559,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}